Oxford Nanopore Technologies PLC
Company Profile
Business description
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing.
Contact
Edmund Halley Road
Gosling Building, Oxford Science Park
OxfordOxfordshireOX4 4DQ
GBRT: +44 8450347900
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
1,315
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,772.00 | 1.00 | -0.01% |
CAC 40 | 7,662.59 | 3.32 | -0.04% |
DAX 40 | 23,673.29 | 236.32 | -0.99% |
Dow JONES (US) | 44,512.14 | 417.37 | 0.95% |
FTSE 100 | 8,785.33 | 24.37 | 0.28% |
HKSE | 24,072.28 | 211.87 | -0.87% |
NASDAQ | 20,212.22 | 157.51 | -0.77% |
Nikkei 225 | 39,986.33 | 501.06 | -1.24% |
NZX 50 Index | 12,734.53 | 131.71 | 1.05% |
S&P 500 | 6,199.11 | 5.84 | -0.09% |
S&P/ASX 200 | 8,541.10 | 1.20 | -0.01% |
SSE Composite Index | 3,444.43 | 20.20 | 0.59% |